ArticleLiver cancer2020

Exploratory Analysis to Identify Candidates Benefitting from Combination Therapy of Transarterial Chemoembolization and Sorafenib for First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Observational Study.

Zhexuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.